Biweekly cetuximab and irinotecan in advanced colorectal cancer patients progressing after at least one previous line of chemotherapy: results of a phase II single institution trial

This is a phase II institutional exploratory trial of biweekly irinotecan and cetuximab administration regimen in metastatic colorectal cancer patients progressing to at least one previous chemotherapy line. A total of 40 patients were treated between November 2005 and November 2007 with irinotecan...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-Martorell, P, Roselló, S, Rodríguez-Braun, E, Chirivella, I, Bosch, A, Cervantes, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527794/
https://www.ncbi.nlm.nih.gov/pubmed/18665167
http://dx.doi.org/10.1038/sj.bjc.6604530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527794/
https://www.ncbi.nlm.nih.gov/pubmed/18665167
http://dx.doi.org/10.1038/sj.bjc.6604530

Ejemplares similares